Celebrating 20 Years of AHF Uganda Cares!

KAMPALA, Uganda–(BUSINESS WIRE)–Twenty years serving Uganda! AHF Uganda Cares, one of AIDS Healthcare Foundation’s first and longest-running global programs, is celebrating its 20th anniversary this month under its “Keeping the Promise” pledge to save lives and combat HIV/AIDS in the country. AHF began providing lifesaving antiretroviral treatment (ART) to people living with HIV in Uganda … [Read more…]

First Patient Dosed in CAN108 (Maralixibat) EMBARK Phase 2 Study in Biliary Atresia in China

China Study is Part of Global EMBARK Study BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals Inc. (HKEX:1228), a leading China and US-based global biopharmaceutical company committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, announced that the first patient has been dosed in the Phase 2 EMBARK study of CAN108 … [Read more…]

AHF: All Levels of Govt. Failing Gay Men on Monkeypox

AHF declared that federal, state and local public health and elected officials are grossly mishandling the response to the monkeypox outbreak that primarily affects gay men and men who have sex with men In a press conference today, AHF called on the Los Angeles County Department of Public Health to implement a proposed six-point plan … [Read more…]

Greenbrook TMS Announces Closing of Success TMS Acquisition and US$75 Million Credit Facility With Madryn Asset Management

TORONTO–(BUSINESS WIRE)–Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, is pleased to announce the closing of its previously-announced acquisition (the “Acquisition”) of Check Five LLC, a Delaware limited liability company (doing business as “Success TMS”) (“Success TMS”). In addition, … [Read more…]

MedX Announces Closing of First Tranche of Non-Brokered Private Placement of Convertible Loan Notes and Also Announces Application for Warrant Extension

MISSISSAUGA, Ontario–(BUSINESS WIRE)–$MDX #SkinCancer—MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX) is pleased to announce that it has closed on the First tranche, of $250,000, of the non-brokered Private Placement announced in its Press Release of June 30, 2022. The Placement is to accredited investors of up to a total of $4 million, by … [Read more…]

Owlet Unveils Predictive Baby Sleep Technology and Next-Generation Nursery Camera

LEHI, Utah–(BUSINESS WIRE)–This week, Owlet (NYSE: OWLT, “the Company”), the brand that has monitored more than one million babies, announced two new innovations to help parents, and their babies, get better sleep: Predictive Sleep Technology and the Owlet Cam 2. Predictive Sleep Technology is a completely automated sleep tool that tracks a baby’s sleep and … [Read more…]

Labcorp Declares Quarterly Dividend

BURLINGTON, N.C.–(BUSINESS WIRE)–Labcorp (NYSE: LH) (the Company), a leading global life sciences company, announced today that its Board of Directors (the Board) has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on September 9, 2022, to stockholders of record as of the close of business on August … [Read more…]

Veracyte to Release Second Quarter 2022 Financial Results on August 2, 2022

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release financial results for the second quarter of 2022 after the close of market on Tuesday, August 2, 2022. Company management will host a conference call and webcast to discuss financial results and provide a general business update at 4:30 p.m. Eastern … [Read more…]

Aurinia Announces the Addition of Three Seasoned Executive Leaders to Advance Company Strategy and Performance

Volker Knappertz, MD, as Executive Vice President, Research and Development, to lead the consolidated R&D function and to further enhance and advance the Aurinia pipeline Scott Habig, as Chief Commercial Officer, to lead and enhance Aurinia’s commercial capabilities, replacing Max Colao, who led the formation of the commercial organization and the launch of Aurinia’s first … [Read more…]